ExirNanoSina

ExirNanoSina is a leading Iranian biotechnology company focused on the development and production of nanomedicines using advanced drug delivery platforms. The company specializes in liposomal and micellar technologies to enhance the therapeutic index of pharmaceutical compounds, particularly in oncology and infectious diseases. Its flagship products include SinaDoxosome, a liposomal formulation of doxorubicin, and SinaAmpholeish, a specialized topical treatment for Leishmaniasis. Based in Tehran and originating as a spin-off from Mashhad University of Medical Sciences, ExirNanoSina maintains GMP-certified facilities for the large-scale manufacturing of nano-encapsulated drugs. The firm plays a critical role in the regional pharmaceutical landscape by providing high-tech alternatives to expensive imported biopharmaceuticals. ExirNanoSina continues to expand its pipeline with new nanomicellar formulations targeting chronic inflammatory conditions and various cancers.